Zealand Pharma increases its share capital as a result of the exercise of employee warrants

Zealand Pharma increased its share capital by DKK 53,183 through the exercise of employee warrants under its incentive scheme. The company issued 53,183 new shares at exercise prices of DKK 90.70 and DKK 218 per share, generating total proceeds of DKK 10,658,111.70. Following registration, the company's total share capital will be DKK 71,578,758 divided into 71,578,758 shares.